Prevention of thrombosis in Covid-19 patients: Only a small number of ongoing US Trials investigating NOACs in the outpatient setting

thrombosis
The two ongoing US trials identified in GlobalData’s database have indicated that NOACs, specifically factor Xa inhibitors, are being investigated in Covid-19 studies. Credit: Shuttterstock.